CLINICAL TRIALS PROFILE FOR VANIQA
✉ Email this page to a colleague
All Clinical Trials for VANIQA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00601640 ↗ | Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin | Completed | National Cancer Institute (NCI) | Phase 2 | 2007-01-01 | RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of eflornithine and diclofenac may stop cancer from growing in patients with sun-damaged skin. PURPOSE: This randomized phase II trial is studying the side effects and how well eflornithine works compared with diclofenac, given alone or together, in treating patients with sun-damaged skin. |
NCT00601640 ↗ | Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin | Completed | University of Arizona | Phase 2 | 2007-01-01 | RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of eflornithine and diclofenac may stop cancer from growing in patients with sun-damaged skin. PURPOSE: This randomized phase II trial is studying the side effects and how well eflornithine works compared with diclofenac, given alone or together, in treating patients with sun-damaged skin. |
NCT01817894 ↗ | Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism | Completed | Bispebjerg Hospital | Phase 4 | 2012-01-01 | Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VANIQA
Condition Name
Clinical Trial Locations for VANIQA
Trials by Country
Clinical Trial Progress for VANIQA
Clinical Trial Phase
Clinical Trial Sponsors for VANIQA
Sponsor Name